GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,433.80p
   
  • Change Today:
      20.80p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.22m
  • Volume: 1,684,051
  • Market Cap: £58,703m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Registrars: Equiniti
Brands: Lucozade, Horlicks, Ribena, Paxil, Seroxat

Key Personnel

CEO: Emma Walmsley
CFO: Iain Mackay
Independent Non-Executive Director: Urs Rohner
Independent Non-Executive Director: Elizabeth (Liz) McKee Anderson
Independent Non-Executive Director: Anne Beal
Independent Non-Executive Director: Jesse Goodman
Independent Non-Executive Director: Harry (Hal) C. Dietz
Independent Non-Executive Director: Vishal Sikka
Non-Executive Chairman: Jonathan Symonds
Senior Independent Non-Executive Director: Charles Bancroft
Non-Executive Dir: Hal Barron

Contact Details

Address: 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS
Phone: +44 (0)20 8047 5000
Website: http://www.gsk.com

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:GSKL, NYSE:GSK
ISIN: GB00BN7SWP63

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,433.80p
Change Today 20.80p
% Change 1.47 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 1,684,051
Shares Issued 4,094.22m
Market Cap £58,703m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.48% above the market average83.48% above the market average83.48% above the market average83.48% above the market average83.48% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
52.76% below the market average52.76% below the market average52.76% below the market average52.76% below the market average52.76% below the market average
24.59% above the sector average24.59% above the sector average24.59% above the sector average24.59% above the sector average24.59% above the sector average
Income
66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
78.44% below the market average78.44% below the market average78.44% below the market average78.44% below the market average78.44% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 15
Sell 1
Strong Sell 1
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 17-Nov-22 18-Aug-22
Paid 12-Jan-23 06-Oct-22
Amount 13.75p 16.25p

Trades for 31-Jan-2023

Time Volume / Share Price
14:08 296 @ 1,433.80p
14:08 481 @ 1,433.80p
14:08 44 @ 1,434.20p
14:08 141 @ 1,434.20p
14:08 53 @ 1,434.20p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page